FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
SERAQUEST VZV IGG
K Number: K972295
·
Decision Nov 5, 1997
Classifications
1
FEI Numbers
11
Registration Numbers
11
Same Product Code
16
Applicant Total
25
Review Days
139
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- SERAQUEST VZV IGG
- K Number
- K972295
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.3900
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Statement
- Applicant
- Quest Intl., Inc.
- Date Received
- June 19, 1997
- Decision Date
- November 5, 1997
- Product Code
- LFY
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LFY | Enzyme Linked Immunoabsorbent Assay, Varicella-Zoster | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (LFY), ordered by most recent decision date.
LIAISON VZV IgG HT, LIAISON Control VZV IgG HT
FDA 510(k)
FDA Class 2
·Microbiology
LIAISON VZV IgG, LIAISON Control VZV IgG
FDA 510(k)
FDA Class 2
·Microbiology
ZEUS SCIENTIFIC, INC VZV IGM ELISA TEST SYSTEM
FDA 510(k)
FDA Class 2
·Microbiology
DIASORIN LIAISON VZV IGG
FDA 510(k)
FDA Class 2
·Microbiology
ZEUS SCIENTIFIC, INC., ATHENA MULTI-LYTE MMRV IGG TEST SYSTEM.
FDA 510(k)
FDA Class 2
·Microbiology
THE APTUS (AUTOMATED) APPLICATION OF THE VZV IGG ELISA TEST SYSTEM
FDA 510(k)
FDA Class 2
·Microbiology
Other Clearances by Quest Intl., Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K091260 | SERAQUEST EBV EA-D IGG TEST | Jun 8, 2009 | Substantially Equivalent |
| K033915 | MODIFICATION TO SERAQUEST EB VCA IGG | Jan 16, 2004 | Substantially Equivalent |
| K033780 | MODIFICATION TO SERAQUEST VCA IGM | Jan 15, 2004 | Substantially Equivalent |
| K023593 | SERAQUEST ANTI-THYROID PEROXIDASE (TPO) | Feb 6, 2003 | Substantially Equivalent |
| K023592 | SERAQUEST ANTI-THYROGLOBULIN | Jan 6, 2003 | Substantially Equivalent |
| K003069 | ANTI-CARDIOLIPIN, MULTIPLE AUTOANTIBODIES IMMUNOLOGICAL TEST SYSTEM | Nov 27, 2000 | Substantially Equivalent |
| K991975 | SERAQUEST EB NA IGG | Nov 2, 1999 | Substantially Equivalent |
| K990410 | SERAQUEST EB VCA IGG | Oct 28, 1999 | Substantially Equivalent |
| K990977 | SERAQUEST EB VAC IGM | Oct 6, 1999 | Substantially Equivalent |
| K982485 | SERAQUEST CMV IGM | Jan 13, 1999 | Substantially Equivalent |